-
Dr. Angela Jia: Rapid Development of Radioligand Therapy, Combined with Local Radiotherapy May Further Improve Survival in Prostate Cancer Patients
Radioligand Therapy (RLT) is an innovative treatment modality in the field of prostate cancer, enriching the therapeutic options. With further research, the personalized application of RLT and its combination with other therapies will become an important direction for the future treatment of prostate cancer. Oncology Frontier invited Dr. Angela Jia, an expert in radiation oncology…
-
Dr. Taiyuan Li: NOSES Surgery – From “Minimally Invasive” to “Scarless” at the Chinese Medical Doctor Association’s Colorectal Oncology Committee
The Rise of NOSES Surgery: From Concept to Clinical Transformation NOSES (Natural Orifice Specimen Extraction Surgery) was first proposed as a surgical concept by Professor Xishan Wang in China. After…
-
Dr. Guiyu Wang: Surgical Updates & Future of Minimally Invasive Treatment | CMDA Colorectal Oncology Annual Meeting
CME Surgery: The Standard Choice for High-Volume Centers Radical surgery remains the cornerstone of colorectal cancer treatment, requiring both complete tumor resection with regional lymph node dissection and the preservation…
-
Dr. Guanghai Dai: MDT’s Role in Colorectal Cancer Treatment | Annual Meeting of the Chinese Medical Doctor Association’s Colorectal Oncology Committee
MDT Evolution: From Exploration to Precision Oncology Multidisciplinary Team (MDT) treatment is a clinical model in which a fixed team of experts from multiple disciplines collaborates regularly to discuss specific…
-
Dr. Wei Zhang: Two Decades of Organ-Preserving Surgery for Low Rectal Cancer in China – Reflections and Future Directions| Annual Meeting of the Chinese Medical Doctor Association’s Colorectal Oncology Committee
At the 9th Annual Meeting of the Chinese Medical Doctor Association’s Colorectal Oncology Committee, Dr. Wei Zhang from The First Affiliated Hospital of the Naval Medical University reviewed the 20-year progress in the treatment of low rectal cancer in China and outlined future directions in the field. His presentation highlighted major advancements in organ-preserving surgery,…
-
Dr. Zheng Lou: Integrating Traditional and Western Medicine to Overcome the Challenge of Anastomotic Leakage After Low Rectal Cancer Surgery| Annual Meeting of the Chinese Medical Doctor Association’s Colorectal Oncology Committee
With changing dietary habits and the increasing adoption of colorectal cancer screening, the incidence of low rectal cancer is on the rise in China. In Shanghai alone, the annual growth rate is estimated at 4.2% to 4.6%, with 70% to 80% of rectal cancers classified as mid-to-low rectal tumors. Despite advancements in surgical techniques, anastomotic…
-
SGBCC Voice of China | Dr. Kun Wang: The Role of Radiomics in Precision Assessment and Prediction of Neoadjuvant Therapy for Breast Cancer
The highly anticipated 19th St. Gallen Breast Cancer Conference (SGBCC) is taking place from March 12 to 15, 2025, in Vienna, Austria, a city renowned for its rich musical heritage. This year’s conference features a special session, “Voice of China,” where leading breast cancer experts from CSCO BC share insights into China’s clinical, basic, and…
-
SGBCC 2025丨Dr. Javier Cortés: The Dual-Edged Breakthrough in Early HER2-Positive Breast Cancer Treatment – Innovative Targeted Drug Development and Trial Design Reform
From March 12 to 15, 2025, the 19th St. Gallen Breast Cancer Conference (SGBCC 2025) was held in Vienna, the City of Music. Leading global experts in breast cancer gathered to discuss cutting-edge advancements and hotly debated topics in breast cancer diagnosis and treatment. At the conference, Dr. Javier Cortés, Head of the International Breast…
Connecting Medical Expertise through Media